CMB International Global Markets  Equity Research  Company Update
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
China Technology Sector
Lily Yang PhD
Mkt Cap (HK mn)
Avg 3 mths to (HK mn)
52w HighLow (HK)
Total Issued Shares (mn)
Source Bloomberg
Shareholding Structure
AVIC International Holdings
HK Securities Clearing
China Asset Management Co
Source HKEx
Source Bloomberg
12-mth Price Performance
Source Bloomberg
Auditor BDO
Recent Reports
1 Substrate demand remains strong in
2022  14 Feb 2022 (Link)
2 Strong 3Q results Cost pressure
remains  2 Nov 2021 (Link)
SZCOMP  (rebased)
HOLD (Maintain)
(Previous TP
RMB11075)
UpDownside
Shennan Circuits FY21 revenue was RMB139bn up 202% YoY NP was
RMB15bn up 35% YoY RevenueNP was largely in line with our forecasts
(6%4% higher than estimates) We saw good revenue growth from substrate and
strong demand from data centerauto clients but overall macro environment
remains tough Given limited incremental capacity to be released this year we
maintain HOLD with unchanged TP of RMB11075
 SubstratePCBA business outperformed PCB in FY21 FY21 revenueNP
grew 202%35% YoY By segment the revenue of PCBPCBAsubstrate
increased 51%672%563% YoY Datacenterauto demand was strong (rev
Shennans core PCB revenue contributor experienced slower growth
Meanwhile PCBs GPM also declined due to lower utilization rate and material
price increase etc but was partially offset by higher substrate GPM as a
result of strong semi demand
 PCB demand from selected subsectors to remain strong but overall
have modest growth in 2022 According to MIIT 600k 5G BTS will be built
this year (vs 654k588k in FY21FY20) Overseas demand could be stronger
as 5G deployment ramps up PCB revenue growth will again be driven by
datacenter and auto demand Nantong factory (Phase III) is expected to
contribute some new capacity as production line continues to ramp up
 Looking forward substrate business will continue to outperform
According to Prismark package substrate is one of the leading growth drivers
among the PCB segments in 2021 Shennans substrate revenue grew 563%
YoY in 2021 Memory orders grew 140% YoY as Wuxi factory has entered
substrate manufacture but new capacity is expected to contribute in 202324
 Maintain HOLD with unchanged TP of RMB11075 We are selectively
optimistic on PCB growth as overall macro environment is tough We believe
substrate and datacenterauto PCB demand will remain very strong Given
limited incremental capacity to be released this year we think the stock is fairly
valued at the moment Maintain HOLD with unchanged TP of RMB11075
(YE 31 Dec)
Turnover (RMB mn)
YoY growth (%)
Gross margin (%)
Net profit (RMB mn)
YoY growth (%)
Consensus EPS (RMB)
Net gearing (%)
Source Company data Bloomberg CMBIGM estimates
Shennan Circuits (002916 CH)
Drivers of FY21 should be able to sustain 
provide a stable revenue growth for FY22
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 1 Earnings revision
EPS (US cents)
Source Company data CMBIGM estimates
Figure 2 CMBIGM estimates vs consensus
EPS (US cents)
Source Company data CMBIGM estimates
Figure 3 12M forward PE band
Source Company data CMBIGM estimates
Figure 4 12M forward PB band
Source Company data CMBIGM estimates
1-yr Forward PE
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
YE 31 Dec (RMB mn)
FY24E  YE 31 Dec (RMB mn)
FY20A FY21A FY22E FY23E FY24E
23080  Net profit
6118  Change in working capital
(385)  Net cash from operating
Admin exp (excl RD)
(1295)  Capex
(179)  Other
Other operating exp
5389  Net cash from investing
Other non-oper exp
(22)  Dividend paid
Pre-tax profit
3420  Other
Net cash from financing
1  Net change in cash
3128  Cash at beginning of the year
Cash at the end of the year
YE 31 Dec (RMB mn)
FY24E  YE 31 Dec
FY20A FY21A FY22E FY23E FY24E
16341  Revenue mix
Cash  equivalents
5982  PCB
4362  PCBA
4012  Substrate
1969  Growth (%)
Non-current assets
11441  Gross profit
8454  Operating profit
150  Net profit
Other non-current
27782  Profit  loss ratio (%)
10309  Operating margin
347  Net profit margin
128  Balance sheet ratio
Other current liabilities
6594  Net debttotal equity (%)
129% Net cash Net cash Net cash
Current ratio  (x)
Non-current liabilities
3427  Receivable turnover days
1843  Inventory turnover days
Deferred tax liability
11  Payable turnover days
Other non-current
13736  Profitability (%)
9674  Per share data (RMB)
14046  BPS
Total liabilities and equity
Source Company data CMBIGM estimates
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Disclosures  Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report in whole or in part certifies that with respect to the securities
or issuer that the analyst covered in this report (1) all of the views expressed accurately reflect his or her personal views about the subject securities
in this report
Besides the analyst confirms that neither the analyst nor hisher associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report (3) serve
covered in this report
 Stock with potential return of over 15% over next 12 months
 Stock with potential return of 15% to -10% over next 12 months
 Stock with potential loss of over 10% over next 12 months
 Stock is not rated by CMBIGM
OUTPERFORM                     Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM             Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM                 Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Global Markets Limited
Address 45F Champion Tower 3 Garden Road Hong Kong Tel (852) 3900 0888   Fax (852) 3900 0800
CMB International Global Markets Limited (CMBIGM) is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned
subsidiary of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities  The information contained in this report may not be suitable for the purposes of all investors  CMBIGM does
not provide individually tailored investment advice This report has been prepared without regard to the individual investment objectives financial position or special
requirements  Past performance has no indication of future performance and actual events may differ materially from that which is contained in the report  The value
of and returns from any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets
to consult with a professional financial advisor in order to make their own investment decisions
This report or any information contained herein have been prepared by the CMBIGM solely for the purpose of supplying information to the clients of CMBIGM or its
affiliate(s) to whom it is distributed  This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or
enter into any transaction  Neither CMBIGM nor any of its affiliates shareholders agents consultants directors officers or employees shall be liable for any loss
damage or expense whatsoever whether direct or consequential incurred in relying on the information contained in this report  Anyone making use of the information
contained in this report does so entirely at their own risk
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable CMBIGM
advices and forecasts on an AS IS basis  The information and contents are subject to change without notice CMBIGM may issue other publications having information
this report As a result recipients should be aware that CMBIGM may have a conflict of interest that could affect the objectivity of this report and CMBIGM will not assume
any responsibility in respect thereof This report is for the use of intended recipients only and this publication may not be reproduced reprinted sold redistributed or
published in whole or in part for any purpose without prior written consent of CMBIGM
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended
from time to time)(The Order) or (II) are persons falling within Article 49(2) (a) to (d) (High Net Worth Companies Unincorporated Associations etc) of the Order and
may not be provided to any other person without the prior written consent of CMBIGM
For recipients of this document in the United States
CMBIGM is not a registered broker-dealer in the United States  As a result CMBIGM is not subject to US rules regarding the preparation of research reports and the
independence of research analysts  The research analyst who is primary responsible for the content of this research report is not registered or qualified as a research
analyst with the Financial Industry Regulatory Authority (FINRA)  The analyst is not subject to applicable restrictions under FINRA Rules intended to ensure that the
analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report This report is intended for distribution in the United States
solely to major US institutional investors as defined in Rule 15a-6 under the US Securities Exchange Act of 1934 as amended and may not be furnished to any other
person in the United States Each major US institutional investor that receives a copy of this report by its acceptance hereof represents and agrees that it shall not
distribute or provide this report to any other person Any US recipient of this report wishing to effect any transaction to buy or sell securities based on the information
provided in this report should do so only through a US-registered broker-dealer
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte Limited (CMBISG) (Company Regn No 201731928D) an Exempt Financial Adviser as defined in the
Financial Advisers Act (Cap 110) of Singapore and regulated by the Monetary Authority of Singapore CMBISG may distribute reports produced by its respective foreign
entities affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations Where the report is distributed
in Singapore to a person who is not an Accredited Investor Expert Investor or an Institutional Investor as defined in the Securities and Futures Act (Cap 289) of
Singapore CMBISG accepts legal responsibility for the contents of the report to such persons only to the extent required by law Singapore recipients should contact
CMBISG at 65 6350 4400 for matters arising from or in connection with the report